James Molloy
Stock Analyst at Alliance Global Partners
(0.61)
# 2,979
Out of 4,412 analysts
27
Total ratings
26.92%
Success rate
-41.34%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUP Ocuphire Pharma | Maintains: Buy | $24 → $20 | $1.61 | +1,142.24% | 2 | Mar 20, 2024 | |
| XRTX XORTX Therapeutics | Maintains: Buy | $9 → $14 | $3.00 | +366.67% | 2 | Jan 4, 2024 | |
| SYBX Synlogic | Initiates: Buy | $30 | $1.87 | +1,504.28% | 1 | Dec 11, 2023 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $18 → $8 | $0.17 | +4,647.77% | 6 | Aug 1, 2023 | |
| NRSN NeuroSense Therapeutics | Initiates: Buy | $7.5 | $1.23 | +509.76% | 1 | Jul 17, 2023 | |
| ALIM Alimera Sciences | Upgrades: Buy | $4.5 → $8 | $3.49 | +129.23% | 2 | Jun 12, 2023 | |
| ABEO Abeona Therapeutics | Reiterates: Buy | $20 | $3.26 | +513.50% | 1 | May 24, 2023 | |
| SLS SELLAS Life Sciences Group | Maintains: Buy | $14 → $8 | $1.46 | +447.95% | 1 | Nov 15, 2022 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $7 | $4.07 | +71.99% | 2 | Nov 4, 2022 | |
| AKTX Akari Therapeutics, | Initiates: Buy | $80 | $1.19 | +6,651.05% | 1 | Nov 1, 2022 | |
| RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $16 | $2.99 | +435.12% | 1 | Nov 1, 2022 | |
| ACXP Acurx Pharmaceuticals | Initiates: Buy | $14 | $2.07 | +576.33% | 1 | Oct 20, 2022 | |
| IMNN Imunon | Initiates: Buy | $15 | $1.44 | +941.67% | 1 | Oct 13, 2022 | |
| QNRX Quoin Pharmaceuticals | Initiates: Buy | $240 | $0.64 | +37,547.06% | 1 | Sep 7, 2022 | |
| CELU Celularity | Initiates: Buy | $150 | $3.02 | +4,866.89% | 1 | Aug 25, 2022 | |
| ENVB Enveric Biosciences | Initiates: Buy | $63 | $0.90 | +6,883.24% | 1 | Jun 1, 2022 | |
| AMPE Ampio Pharmaceuticals | Initiates: Buy | $1,350 | $0.32 | +420,460.75% | 1 | Mar 24, 2022 | |
| ACHV Achieve Life Sciences | Initiates: Buy | n/a | $4.61 | - | 1 | Oct 4, 2021 |
Ocuphire Pharma
Mar 20, 2024
Maintains: Buy
Price Target: $24 → $20
Current: $1.61
Upside: +1,142.24%
XORTX Therapeutics
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $3.00
Upside: +366.67%
Synlogic
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.87
Upside: +1,504.28%
Tonix Pharmaceuticals Holding
Aug 1, 2023
Maintains: Buy
Price Target: $18 → $8
Current: $0.17
Upside: +4,647.77%
NeuroSense Therapeutics
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.23
Upside: +509.76%
Alimera Sciences
Jun 12, 2023
Upgrades: Buy
Price Target: $4.5 → $8
Current: $3.49
Upside: +129.23%
Abeona Therapeutics
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $3.26
Upside: +513.50%
SELLAS Life Sciences Group
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.46
Upside: +447.95%
Aquestive Therapeutics
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $4.07
Upside: +71.99%
Akari Therapeutics,
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.19
Upside: +6,651.05%
Reviva Pharmaceuticals Holdings
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $2.99
Upside: +435.12%
Acurx Pharmaceuticals
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $2.07
Upside: +576.33%
Imunon
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $1.44
Upside: +941.67%
Quoin Pharmaceuticals
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.64
Upside: +37,547.06%
Celularity
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $3.02
Upside: +4,866.89%
Enveric Biosciences
Jun 1, 2022
Initiates: Buy
Price Target: $63
Current: $0.90
Upside: +6,883.24%
Ampio Pharmaceuticals
Mar 24, 2022
Initiates: Buy
Price Target: $1,350
Current: $0.32
Upside: +420,460.75%
Achieve Life Sciences
Oct 4, 2021
Initiates: Buy
Price Target: n/a
Current: $4.61
Upside: -